Form 4: Arteris Director Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris director Saiyed Atiq Raza sold a total of 19,350 shares of common stock in two transactions on December 11 and 12, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Saiyed Atiq Raza, a director at Arteris, Inc., sold 2,400 shares of common stock on December 11, 2024, at a weighted average price of $10.0074.
- On December 12, 2024, Mr. Raza sold an additional 16,950 shares at a weighted average price of $10.1179.
- The sales were executed under a 10b5-1 trading plan adopted on June 6, 2024.
- The shares were sold from the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Mr. Raza serves as trustee.
- Following these transactions, the trust beneficially owns 826,892 shares of Arteris common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Industry Context
This is a routine filing related to insider trading activity and is common for directors and officers of publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned and scheduled sale of shares.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among corporate insiders to avoid accusations of trading on non-public information.
- The reported share sales are relatively small compared to the total shares held by the trust, which is a common pattern for directors who are diversifying their holdings.
- Similar filings are regularly made by directors and officers of other publicly traded companies, such as those in the semiconductor and technology sectors, including companies like ARM Holdings and Synopsys.
Stakeholder Impact
- The share sales by a director may have a minor impact on investor sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2012-11-26 | Date of the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust. |
| 2024-06-06 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 2024-12-11 | Date of the first reported stock sale. |
| 2024-12-12 | Date of the second reported stock sale. |
| 2024-12-13 | Date of the Form 4 filing. |
Keywords
Arteris, insider trading, Form 4, 10b5-1 plan, stock sale, director, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.